Hypercholesterolaemia screening in Type 1 Diabetes: a difference of opinion

T. Candler, O. Mahmoud, J. Edge, J. Hamilton-Shield*

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

4 Citations (Scopus)
191 Downloads (Pure)

Abstract

Aim: To assess cholesterol screening of children with Type 1 diabetes by diabetes professionals using a survey of current practice, given that National Institute of Health and Care Excellence guidelines on childhood Type 1 diabetes do not recommend cholesterol screening, yet the National Paediatric Diabetes Audit has an annual cholesterol measure (> 12 years) as a key outcome indicator. Methods: An online survey was sent to 280 members of the Association of Children's Diabetes Clinicians to assess cholesterol screening practice in children. Results: A total of 87 diabetes professionals (31%) responded. The results showed that 94% of respondents measured cholesterol, 33% did this annually on all children, and 7% measured fasting cholesterol. A total of 63% used no guidelines to decide treatment or further investigation. The definition of 'high' cholesterol varied from > 4.5 to > 8 mmol/l, with 40% giving no response or specific level. Only 14% of clinicians had started statin therapy in their diabetes clinic in the previous 5 years. Conclusion: Whilst the majority of diabetes professionals measured cholesterol in children with Type 1 diabetes, there was marked variability in sampling, in children screened and in action taken if levels were considered abnormal. It is debatable whether cholesterol measures should be undertaken, certainly more than once, and whether cholesterol level should feature as a key outcome in the national audit in future.
Original languageEnglish
Pages (from-to)983-986
Number of pages4
JournalDiabetic Medicine
Volume34
Issue number7
Early online date8 Mar 2017
DOIs
Publication statusPublished - Jul 2017

Bibliographical note

Special Issue on Diabetes Epidemiology

Fingerprint Dive into the research topics of 'Hypercholesterolaemia screening in Type 1 Diabetes: a difference of opinion'. Together they form a unique fingerprint.

Cite this